Advertisement

Topics

CytoDyn Inc. Company Profile

19:15 EDT 20th March 2019 | BioPortfolio

CytoDyn is a biotechnology company focused on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). The Company has one of the leading mAbs under development for HIV infection PRO 140 which is a Late Stage II humanized mAb with demonstrated antiviral activity in man. PRO 140 blocks the HIV co-receptor CCR5 and clinical trial results thus far indicate that it does not affect the normal function of the cell. Results from Phase 1/1b and Phase 2a human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. CytoDyn intends to continue to develop PRO 140 as a therapeutic anti-viral agent in persons infected with HIV. For more information on the Company please visit www.cytodyn.com.


News Articles [35 Associated News Articles listed on BioPortfolio]

CytoDyn aims to be 'paradigm-shifting' in cancer management with its platform drug leronlimab

CytoDyn Inc (OTCQB:CYDY) CytoDyn CEO Nader Pourhassan and CMO Dr. Richard Pestell sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.  The biotechnology co...

CytoDyn seeks FDA OK for triple-negative breast cancer candidate trial

An investigational new drug application was filed by CytoDyn with the FDA for a Phase Ib/II study of PRO 140, or leronlimab,  -More- 

CytoDyn submits first part of biologics license application to FDA for flagship HIV drug leronlimab

CEO Nader Pourhassan described the move as the ‘most important milestone yet in CytoDyn’s history’

FDA accepted CytoDyn’s request and plan to submit BLA on rolling basis

CytoDyn Inc. (OTCQB:CYDY) President and CEO Dr. Nader Pourhassan joined Steve Darling from Proactive Investors Vancouver on Skype to talk about encouraging news that the FDA will allow CytoDyn to su...

CytoDyn’s leronlimab reduces by more than 98% human breast cancer metastasis in mouse xenografts

Based on strong results in its preclinical animal study, CytoDyn files for Orphan Drug designation for triple-negative breast cancer

CytoDyn Inc.'s President Talks with Uptick Newswire's Stock Day Podcast About Exciting New FDA Trials for HIV and Cancer Treatments

PHOENIX, AZ / ACCESSWIRE / November 9, 2018 / CytoDyn Inc. (OTCQB: CYDY) (the "company"), is a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic i...

CytoDyn’s flagship leronlimab product reduces by more than 98% human breast cancer metastasis in mouse xenografts

Based on strong results in its preclinical animal study, CytoDyn files for Orphan Drug designation for triple-negative breast cancer

STAT Plus: Taking the measure of small-cap biotech: Bio-Path Holdings, CytoDyn

>@adamfeuerstein takes a closer look at two biotech companies, Bio-Path Holdings and CytoDyn, and hoists some red flags in each case.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

CytoDyn Inc.

CytoDyn is a biotechnology company focused on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and pr...

CytoDyn, Inc.

More Information about "CytoDyn Inc." on BioPortfolio

We have published hundreds of CytoDyn Inc. news stories on BioPortfolio along with dozens of CytoDyn Inc. Clinical Trials and PubMed Articles about CytoDyn Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytoDyn Inc. Companies in our database. You can also find out about relevant CytoDyn Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record